Purchase Order HT001422P0117
Award Date
4/27/22
Potential Completion Date
4/24/23
Potential Value
$217K
Federal Agency
Defense Health Agency
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Immucor Inc. for the yearly supply of PANOCELL-20 and FMH RAPID SCREEN diagnostic products. The award is valued at $9,931.60 and does not have a set-aside designation. Immucor is a manufacturer of in vitro diagnostics, reagents, and equipment for blood transfusion and transplantation compatibility testing. The company has held multiple federal contracts to provide specialized medical...
This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
The Defense Health Agency awarded a firm-fixed-price purchase order to Immucor Inc., a for-profit manufacturer of goods, for the delivery of blood typing reagents. The $228,353.45 contract has an ultimate completion date of September 30, 2027. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood banking supplies to federal agencies such as the Department of Veterans Affairs and the Indian Health Service. This award is not set aside and is...
This federal contract award is for a yearly standing order for PANOCELL-20 20X3 and FMH RAPIDSCREEN KITS placed by the Bureau of Medicine and Surgery, a defense agency, with the prime contractor Immucor Inc. The $10,671.69 firm fixed price purchase order has a completion date of September 30, 2017. There is no set-aside designation for this award. Immucor Inc. is a manufacturer of in vitro diagnostic products, reagents, and blood banking equipment, and has a history of providing supplies and...
This federal contract award, valued at $244,758.17, was issued by the Defense Health Agency to Immucor Inc., a manufacturer of goods, for the delivery of CAP R RS (3) 5 PLATE DOMESTIC. The contract is a firm fixed-price purchase order without a set-aside designation, with a period of performance through May 31, 2024. Immucor is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The company has a history...
This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract is for the provision of blood typing reagents, with a ceiling value of $121,323.95 and a completion date of September 30, 2020. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare agencies, including the Department of Veterans...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 9 (VISN 9) of the U.S. Department of Veterans Affairs (VA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The $14,767.48 contract is for the delivery of Immucor blood products to support the VA's blood transfusion and transplantation compatibility testing requirements. Immucor has a history of providing specialized reagents, blood analyzers, and related consumables to federal...
This is a $4,970.47 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract provides Immucor's specialized reagents, blood analyzers, testing equipment, and related consumables to support blood typing, compatibility testing, antibody screening, and critical blood banking operations within federal health networks and military treatment centers. Immucor has a...